E3 PreliminaryWeak / uncertainPEM ?Review-NarrativePeer-reviewedMachine draft
Chronic fatigue syndrome: a review for clinicians.
Goshorn, R K · Seminars in neurology · 1998 · DOI
Quick Summary
This review explains that ME/CFS is a real condition characterized by long-lasting fatigue, muscle and joint pain, sleep problems, and thinking difficulties. While doctors don't yet fully understand what causes ME/CFS, research suggests it involves subtle problems with the nervous system, hormones, and immune function. Treatment focuses on managing symptoms to help patients feel better, though the approach is personalized since every patient is different.
Why It Matters
This review addresses a critical gap in clinical understanding by emphasizing that ME/CFS is a legitimate medical condition deserving systematic investigation and compassionate care. It validates the experiences of patients experiencing multiple overlapping symptoms and advocates for standardized research definitions to accelerate understanding of disease mechanisms. The paper's emphasis on skillful clinical management offers practical guidance for healthcare providers treating ME/CFS patients.
Observed Findings
- ME/CFS commonly presents with persistent fatigue, musculoskeletal pain, sleep disturbance, and cognitive impairment.
- Subtle neuroendocrine abnormalities are associated with ME/CFS.
- Subtle immunologic abnormalities are associated with ME/CFS.
- Standardized case definitions are needed to ensure consistent patient populations in research.
Inferred Conclusions
- The pathogenesis of ME/CFS involves neuroendocrine and immunologic mechanisms, though the exact mechanisms remain unknown.
- Systematic case definitions are essential for standardizing research and advancing understanding of ME/CFS etiology.
- Treatment of ME/CFS requires individualized, empirical approaches focused on symptom palliation rather than cure.
Remaining Questions
- What are the specific neuroendocrine abnormalities underlying ME/CFS, and are they causative or reactive?
- Which immunologic mechanisms are abnormal in ME/CFS, and what initiates these changes?
- What evidence-based treatment approaches are most effective for different ME/CFS symptoms?
- Are there biomarkers that could aid in diagnosis and monitor disease progression?
What This Study Does Not Prove
This editorial does not present original research data or identify definitive causes of ME/CFS. It cannot establish which specific neuroendocrine or immunologic abnormalities are primary versus secondary consequences of the illness. The review does not prove that any particular treatment is effective—it only acknowledges that symptom management is possible with careful medical practice.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepPainFatigue
Biomarker:Cytokines
Method Flag:Exploratory Only
Metadata
- DOI
- 10.1055/s-2008-1040876
- PMID
- 9608620
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026